Related Experiment Video
Updated: Aug 8, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The pacemaker and implantable cardioverter defibrillator recall issue - a Canadian perspective
Christopher S Simpson1, Anne M Gillis
1Division of Cardiology, Kingston General Hospital, Queen's University, Ontario. simpsonc@kgh.kari.net
Insights
In 2005, numerous pacemakers and implantable cardioverter defibrillators were recalled, causing patient concern. Reforms in postmarket analysis and reporting are needed for better device safety and physician confidence.
Area of Science:
- Cardiology
- Biomedical Engineering
- Public Health
Background:
- In 2005, the cardiac rhythm device industry faced an unprecedented number of recalls for pacemakers and implantable cardioverter defibrillators.
- The large scale of these recalls generated significant concern among patients and healthcare providers regarding device safety and efficacy.
Purpose of the Study:
- To address the challenges and concerns arising from widespread cardiac device recalls.
- To provide a Canadian perspective on the international issue of postmarket surveillance for implantable electronic devices.
- To propose solutions for improving postmarket analysis and reporting mechanisms.
Main Methods:
- The study reviews the events of 2005 concerning cardiac device recalls.
- It analyzes the impact on physician decision-making regarding device replacement.
- It discusses the need for reform in postmarket surveillance and reporting.
Main Results:
- Physicians often lacked timely, well-defined information on risks and consequences of device failure, leading to uncertainty in recommending device replacement.
- There is a clear call from physicians and patients for reform in postmarket analysis and reporting.
Conclusions:
- Potential solutions include establishing realistic expectations, restoring confidence in postmarket surveillance, enhancing data transparency, and increasing the involvement of patient and physician groups.
- A multi-faceted approach is required to improve the safety and reliability of cardiac rhythm devices.
Abstract:
In 2005, an unprecedented number of recalls were issued on pacemakers and implantable cardioverter defibrillators. While recalls in the cardiac rhythm device industry are not new, the sheer magnitude of potentially affected patients in 2005 led to a great deal of concern, frustration, and even anger. Physicians have, in many instances, been uncertain when (or if) to recommend device replacement in an environment where the magnitude of the risk and the potential consequences of device failure have not been well defined in a timely way. Doctors and patients are now calling for reform of postmarket analysis and reporting mechanisms. The present article provides a uniquely Canadian perspective on this international issue. Potential solutions include the development of a set of realistic and common expectations, a restoration of confidence in postmarket analysis and reporting mechanisms, increased data transparency, and an increased role for patient and physician groups.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
